SZN-8143

N/A

Report date: 2024/11/29 11:39:36

Base Information

Drug NameSZN-8143
Drug Alias NameSZN-8143
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionFrizzled-4 modulatorsAnti-Vascular endothelial growth factorAnti-Interleukin-6
TargetsFrizzled-4Vascular endothelial growth factorInterleukin-6
Therapy Area/IndicationsDiabetic macular oedemaUveitisMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSurrozen Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurrozen Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaUveitisMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A